A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/20 (2006.01) A61K 31/07 (2006.01) A61K 31/203 (2006.01) C12N 5/12 (2006.01) C12Q 1/02 (2006.01) C12N 5/06 (2006.01) C12N 5/08 (2006.01)
Patent
CA 2218685
Method for mediating the expression by mammalian cells of Fas-Ligand following activation using retinoid compounds, and specifically retinoid compounds which activate both retinoid X receptors and retinoic acid receptors. Examples of such retinoid compounds are 9-cis retinoic acid and related compounds. The method provides a means for inhibiting apoptosis in cells which express Fas-Ligand following activation.
Procédé d'induction de l'expression de ligands de FAS par des cellules de mammifères après activation à l'aide de composés de rétinoïde et plus particulièrement de composés de rétinoïde activant à la fois les récepteurs du rétinoïde X et de l'acide rétinoïque. L'acide 9-cis rétinoïque et les composés associés constituent des exemples de ces composés de rétinoïde. Ce procédé permet d'obtenir un moyen d'inhiber l'apoptose dans des cellules exprimant des ligands de FAS après activation.
Bissonnette Reid P.
Heyman Richard A.
Ligand Pharmaceuticals Incorporated
Smart & Biggar
LandOfFree
Inhibition of apoptosis in cells expressing fas-ligand... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Inhibition of apoptosis in cells expressing fas-ligand..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibition of apoptosis in cells expressing fas-ligand... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1919545